Myeloproliferative disorders (MPD)

''Myeloproliferative disorders(MPD) are relatively rare chronic hematologic malignancies that include the classic myeloproliferative disorders:

Philadelphia chromosome-negative                Philadelphia chromosome-positive
   Essential Thrombocythemia (ET)                     Chronic Myelogenous Leukemia (CML)
   Myelofibrosis (MF)
   Polycythemia Vera (PV)

There are atypical myeloproliferative disorders which include molecularly defined PDGFRA-rearranged eosinophilic/mast cell disorders; PDGFRB-rearranged eosinophilic disorders; systemic mastocytosis associated with c-kit mutation; 8p11 Myeloproliferative syndrome; and juvenile myelomonocytic leukemia with recurrent mutations of RAS. MPD also includes the clinicopathologically assigned variants: chronic neutrophilic leukemia; chronic eosinophilic leukemia; hypereosinophillic syndrome, chronic basophilic leukemia, chronic monomyelomonocytic leukemia, systemic mastocytosis; and unclassified myeloproliferative disorder. Chronic myeloid disorders also include myelodysplastic syndrome.''

Extract of MPD INFO
____________________________________________________________________________________________

Risk of second cancers in chronic myeloproliferative neoplasms.
April 19, 2012, PubLMed

BHC Nurses myeloproliferative diseases (MPD)                                                              VIDEO
August31, 2008,  jmuscato2  

Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era
2006, American Society of Hematology